Patent details

EP3603638 Title: COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR

Basic Information

Publication number:
EP3603638
PCT Application Number:
JP2018011560
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187706411
PCT Publication Number:
WO2018174219
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR
French Title of Invention:
TECHNIQUE DE POLYTHÉRAPIE POUR AGENT INHIBITEUR D'AXL ET INHIBITEUR DE TYROSINE KINASE DE L'EGFR
German Title of Invention:
KOMBINATIONSTHERAPIETECHNIK FÜR AXL-HEMMENDES MITTEL UND EGFR-TYROSINKINASE-INHIBITOR
SPC Number:

Dates

Filing date:
23/03/2018
Grant date:
13/12/2023
EP Publication Date:
05/02/2020
PCT Publication Date:
27/09/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/12/2023
EP B1 Publication Date:
13/12/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/03/2024
Expiration date:
23/03/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/12/2023
 
 

Name:
Daiichi Sankyo Company, Limited
Address:
3-5-1, Nihonbashi-honcho Chuo-ku, Tokyo 103-8426, Japan (JP)

Inventor

Name:
JIMBO, Takeshi
Address:
Japan (JP)

Priority

Priority Number:
2017058858
Priority Date:
24/03/2017
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/444; A61K 31/506; A61K 45/00; A61P 35/00; A61P 35/02; A61P 43/00; A61K 31/517; A61K 31/5377; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202350
Publication date:
13/12/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages